At a glance
ClinicalIndex Comparison RecordN/ACompleted· 545 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms
In Brief
An observational study for Breast Cancer and 4 related conditions. Completed, enrolled 545 participants across 1 site.
Detailed Summary
The study is a prospective cohort study following breast cancer patients from before surgery to one year after. The aims of the study are to determine risk factors that predispose to the development of persistent pain.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer, Persistent Pain, Lymphedema, Neuropathic Pain, Neuropathy
CountriesDenmark
CollaboratorsDanish Breast Cancer Cooperative Group, Danish Cancer Society
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2011
First PostedFeb 2012
Primary CompletionNov 2014
TodayJul 2026
First PostedFeb 1, 2012
Enrollment StartNov 1, 2011
Primary CompletionNov 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 14.4 years ago